Stifel analyst Mark Astrachan downgraded IFF to Hold from Buy with a price target of $85, down from $123. IFF reported disappointing Q2 results and reduced its 2023 sales and adjusted EBITDA guidance by 7% and 18%, respectively, the analyst tells investors in a research note. The firm says the miss and lowered guidance largely reflects ongoing customer destocking, hurting volumes and resulting in more significant manufacturing absorption costs related to improving inventories. Stifel anticipates IFF shares will trade down meaningfully on the results.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on IFF: